MEDIGENE N (MDG1.SG)
MEDIGENE N (MDG1.SG) operates in Diversified Metals & Mining.
MEDIGENE N (MDG1.SG) (MDG1) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2019: -0.087x
Based on the latest financial reports, MEDIGENE N (MDG1.SG) (MDG1) has a cash flow conversion efficiency ratio of -0.087x as of December 2019.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-7.10 Million) by net assets (€81.82 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MEDIGENE N (MDG1.SG) - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how MEDIGENE N (MDG1.SG)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MEDIGENE N (MDG1.SG) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MEDIGENE N (MDG1.SG) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DIAMOND FIELDS RES
F:D2DA
|
N/A |
|
FOACW
PINK:FOACW
|
N/A |
|
TRANSNATIONAL CORPORATION OF NIGERIA PLC
XNSA:TRANSCORP
|
N/A |
|
Agstar PLC
CM:AGSTN0000
|
N/A |
|
Dundas Minerals Ltd
AU:DUN
|
-0.068x |
|
MAGNUM MINING & EXP
BE:M8Z
|
N/A |
|
El Wadi For International and Investement Development
EGX:WACE
|
N/A |
|
Eloxx Pharmaceuticals Inc
PINK:ELOX
|
0.172x |
Annual Cash Flow Conversion Efficiency for MEDIGENE N (MDG1.SG) (2016–2023)
The table below shows the annual cash flow conversion efficiency of MEDIGENE N (MDG1.SG) from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €21.07 Million | €-15.12 Million | -0.718x | -321.88% |
| 2022-12-31 | €37.03 Million | €11.98 Million | 0.323x | +234.79% |
| 2021-12-31 | €44.82 Million | €-10.75 Million | -0.240x | +48.54% |
| 2020-12-31 | €53.15 Million | €-24.79 Million | -0.466x | -132.33% |
| 2019-12-31 | €81.82 Million | €-16.42 Million | -0.201x | -112.60% |
| 2018-12-31 | €107.42 Million | €-10.14 Million | -0.094x | +60.98% |
| 2017-12-31 | €86.17 Million | €-20.85 Million | -0.242x | -406.02% |
| 2016-12-31 | €78.59 Million | €-3.76 Million | -0.048x | -- |